Tocilizumab in Covid-19 Pneumonia

Severe Covid-19 pneumonia occurs in approximately 15% of patients and is associated with high mortality. Case reports and observational studies have suggested that treatment with tocilizumab causes rapid fever reduction and reduces need for oxygen support. New research findings are summarized in a short video.

https://www.nejm.org/do/10.1056/NEJMdo005991/full/

Créditos: Comité científico Covid